Jack J. Hawiger
26Patents
9h-index
19Co-inventors
72Inventor score
Filing activity: Apr 10, 1984 → Jun 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5807746A | Method for importing biologically active molecules into cells | Chemistry; Metallurgy | 95 | Expired |
| US6043339A | Method for importing biologically active molecules into cells | Chemistry; Metallurgy | 76 | Expired |
| US4703039A | Method of producing biologically active molecules having extended life time | Human Necessities | 51 | Expired |
| US4661471A | Method of inhibiting and inducing human platelet aggregation | Human Necessities | 31 | Expired |
| US6495518B1 | Method for importing biologically active molecules into cells | Emerging Cross-Sectional Technologies | 30 | Expired |
| US8420096B2 | Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling | Chemistry; Metallurgy | 18 | Expired |
| US4666884A | Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls | Human Necessities | 17 | Expired |
| US7553929B2 | Cell permeable peptides for inhibition of inflammatory reactions and methods of use | Chemistry; Metallurgy | 12 | Expired |
| US8324148B2 | Compositions for importing biologically active molecules into cells | Emerging Cross-Sectional Technologies | 9 | Expired |
| US9044433B2 | Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome | Human Necessities | 9 | Active |
| US8932559B2 | Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes | Human Necessities | 7 | Active |
| US7576058B1 | Method for importing biologically active molecules into cells | Chemistry; Metallurgy | 6 | Expired |
| US9492544B2 | Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders | Chemistry; Metallurgy | 4 | Active |
| US9388224B2 | Compositions for preserving insulin-producing cells and insulin production and treating diabetes | Chemistry; Metallurgy | 2 | Active |
| US9370549B2 | Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome | Human Necessities | 2 | Active |
| US10568928B2 | Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders | Chemistry; Metallurgy | 1 | Active |
| US11364278B2 | Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders | Chemistry; Metallurgy | 1 | Active |
| US9808501B2 | Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome | Human Necessities | 1 | Active |
| US10272133B2 | Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome | Human Necessities | 1 | Active |
| US11571455B2 | Methods and compositions for treating alcoholic liver disease | Chemistry; Metallurgy | 1 | Active |
| US11026992B2 | Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation | Chemistry; Metallurgy | 0 | Active |
| US10342847B2 | Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation | Chemistry; Metallurgy | 0 | Active |
| US11951150B2 | Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation | Chemistry; Metallurgy | 0 | Active |
| US12060396B2 | Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis | Chemistry; Metallurgy | 0 | Active |
| US11771739B2 | Methods and compositions for treating microbial inflammation | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.